297568
Emergency Medicine Physician Attitudes towards HPV vaccine uptake in an emergency department setting
Methods: A cross sectional study using an 11-item survey with a response format utilizing a validated Likert scale, was used to assess physician attitudes of 50 EM physicians (19 EM attending physicians and 31 resident physicians) towards recommending the HPV vaccine in an ED setting to age eligible patients.
Results: 67.4% stated they would recommend the vaccine, 23.9% were neutral, and 8.7% would not recommend the vaccine to age eligible patients in the ED. 41% noted lack of adequate reimbursement for vaccination as a barrier to vaccination in the ED (p <.05). Physicians were comfortable targeting women at high risk for cervical cancer for vaccination (p <.05).
Conclusion: Local EM physicians are comfortable targeting high-risk women for HPV vaccination in an ED setting. Support of EM physicians in the national effort to improve HPV vaccine uptake is an important step in eradicating a largely preventable yet lethal cancer.
Learning Areas:
Clinical medicine applied in public healthDiversity and culture
Provision of health care to the public
Public health administration or related administration
Public health or related organizational policy, standards, or other guidelines
Social and behavioral sciences
Learning Objectives:
Identify the attitudes of physicians serving in the emergency department, the public healthy safety net, towards HPV vaccine initiation efforts in their clinical an environment.
Evaluate the importance of prevention efforts among EM physicians who serve a population who likely does not have routine access to health care services.
Keyword(s): Cancer Prevention and Screening, Emergency Medical Services
Qualified on the content I am responsible for because: As the co-author of this abstract and research coordinator on the study, I am qualified as an abstract author.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.